Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms
Open Access
- 1 November 2013
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 64, 20-29
Abstract
No abstract availableKeywords
Funding Information
- Utah Biomedical Research Core Center (P30) in Metabolism and Cardiovascular Disease Grant
- National Institute of Health (P30 HL101310, R01DK092065, U01 HL087947)
This publication has 55 references indexed in Scilit:
- Preconditioning the diabetic human myocardiumJournal of Cellular and Molecular Medicine, 2010
- Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodentsJournal of Clinical Investigation, 2010
- Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunctionEuropean Heart Journal, 2009
- Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarctionJournal of Molecular and Cellular Cardiology, 2009
- Contribution of Insulin and Akt1 Signaling to Endothelial Nitric Oxide Synthase in the Regulation of Endothelial Function and Blood PressureCirculation Research, 2009
- Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failureJournal of Clinical Investigation, 2005
- Failure to precondition pathological human myocardiumJACC, 2001
- Therapeutic potential of ischaemic preconditioningBritish Journal of Clinical Pharmacology, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998